Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 10;3(1):109.
doi: 10.1186/s43058-022-00355-6.

Applying implementation frameworks to the clinical trial context

Affiliations

Applying implementation frameworks to the clinical trial context

Kristian D Stensland et al. Implement Sci Commun. .

Erratum in

Abstract

Background: Clinical trials advance science, benefit society, and provide optimal care to individuals with some conditions, such as cancer. However, clinical trials often fail to reach their endpoints, and low participant enrollment remains a critical problem with trial conduct. In these ways, clinical trials can be considered beneficial evidence-based practices suffering from poor implementation. Prior approaches to improving trials have had difficulties with reproducibility and limited impact, perhaps due to the lack of an underlying trial improvement framework. For these reasons, we propose adapting implementation science frameworks to the clinical trial context to improve the implementation of clinical trials.

Main text: We adapted an outcomes framework (Proctor's Implementation Outcomes Framework) and a determinants framework (the Consolidated Framework for Implementation Research) to the trial context. We linked these frameworks to ERIC-based improvement strategies and present an inferential process model for identifying and selecting trial improvement strategies based on the Implementation Research Logic Model. We describe example applications of the framework components to the trial context and present a worked example of our model applied to a trial with poor enrollment. We then consider the implications of this approach on improving existing trials, the design of future trials, and assessing trial improvement interventions. Additionally, we consider the use of implementation science in the clinical trial context, and how clinical trials can be "test cases" for implementation research.

Conclusions: Clinical trials can be considered beneficial evidence-based interventions suffering from poor implementation. Adapting implementation science approaches to the clinical trial context can provide frameworks for contextual assessment, outcome measurement, targeted interventions, and a shared vocabulary for clinical trial improvement. Additionally, exploring implementation frameworks in the trial context can advance the science of implementation through both "test cases" and providing fertile ground for implementation intervention design and testing.

Keywords: Clinical trials; Consolidated framework for implementation research; Determinants; Implementation mapping; Implementation outcomes; Implementation research logic model.

PubMed Disclaimer

Conflict of interest statement

The authors declare that Anne Sales is co-Editor-in-Chief of the journal.

Figures

Fig. 1
Fig. 1
Implementation, service, and client outcomes adapted to the clinical trial context
Fig. 2
Fig. 2
Adapted implementation research logic model (IRLM) applied to the clinical trial-side outcome of poor enrollment. *Note: arrows indicate inferential flow, not causal representations

Similar articles

Cited by

References

    1. Grand View Research. Clinical trials market size, share & trends analysis report by phase (phase I, phase II, phase III, phase IV), by study design (interventional, observational, expanded access), by indication, by region, and segment forecasts, 2021–2028. Available from: https://www.grandviewresearch.com/industry-analysis/global-clinical-tria.... cited 2021 Jul 30
    1. Denburg A, Rodriguez-Galindo C, Joffe S. Clinical trials infrastructure as a quality improvement intervention in low- and middle-income countries. Am J Bioeth. 2016;16:3–11. doi: 10.1080/15265161.2016.1170230. - DOI - PubMed
    1. NCCN Guidelines. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. 2021. Available from: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. cited 2021 Feb 5
    1. Stensland K, Kaffenberger S, Canes D, Galsky M, Skolarus T, Moinzadeh A. Assessing genitourinary cancer clinical trial accrual sufficiency using archived trial data. JCO Clin Cancer Inform. 2020;4:614–622. doi: 10.1200/CCI.20.00031. - DOI - PubMed
    1. Stensland KD, McBride RB, Latif A, Wisnivesky J, Hendricks R, Roper N, et al. Adult cancer clinical trials that fail to complete: an epidemic? J Natl Cancer Inst. 2014;106:dju229. doi: 10.1093/jnci/dju229. - DOI - PubMed

LinkOut - more resources